Recombinant Human TNFAIP3 Protein，His & GST

TNFAIP3, also known as A20, is a potent anti-inflammatory protein that plays a crucial role in the regulation of the immune response and the maintenance of cellular homeostasis. Functioning primarily as a negative regulator of the NF-κB signaling pathway, TNFAIP3 modulates inflammation and apoptosis by promoting ubiquitination and degradation of signaling molecules. Dysregulation of TNFAIP3 has been implicated in various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease, where its reduced expression or dysfunctional mutations contribute to chronic inflammation. The therapeutic potential of TNFAIP3 and its reconstitution has garnered significant interest in the biomedical field. Researchers are investigating the recombinant expression of TNFAIP3 to better understand its structure-function relationship, elucidate its mechanistic role in signaling pathways, and develop novel therapeutic strategies aimed at restoring its function in disease contexts. By studying the restructured protein, scientists aim to address the challenges posed by its complex regulation and interactions, enabling advancements in targeted therapies that could mitigate autoimmune conditions and enhance overall immune system balance. This line of research holds promise for developing innovative treatments that can harness the protective effects of TNFAIP3, underscoring its importance in both fundamental immunology and clinical applications.